Ministry of Food and Drug Safety completes inspection at Concord Biotech's Dholka unit

The Ministry of Food and Drug Safety (MFDS) (formerly the Korea Food and Drug Administration (KFDA) has conducted an inspection at Company's Manufacturing Unit I, (API facility), located at Dholka, Gujarat from Tuesday, 18th February, 2025 to Thursday 20th February, 2025.

The inspection was successfully completed. This achievement underscores our unwavering commitment to maintain world-class quality systems and standards. We remain dedicated to delivering the highest quality products to our customers, reinforcing our position as a leader in the industry.

Shares of Concord Biotech Limited was last trading in BSE at Rs. 1677.75 as compared to the previous close of Rs. 1763.60. The total number of shares traded during the day was 7359 in over 707 trades.

The stock hit an intraday high of Rs. 1750.05 and intraday low of 1661.05. The net turnover during the day was Rs. 12564681.00.

Source : Equity Bulls

Keywords

ConcordBiotech Pharmaceuticals INE338H01029 MFDS Inspection DholkaUnit